Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderately to Severely Active Crohns Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT03009396
What this trial is testing

Open Label Efficacy and Safety of Anti-MAP (Mycobacterium Avium Ssp. Paratuberculosis) Therapy in Adult Crohn's Disease

Who this might be right for
Crohn Disease
RedHill Biopharma Limited 54
Testing effectiveness (Phase 2)Looking for participantsNCT06226883
What this trial is testing

Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

Who this might be right for
Inflammatory Bowel DiseasesCrohn's Disease
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company) 385
Testing effectiveness (Phase 2)Looking for participantsNCT06764615
What this trial is testing

A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)

Who this might be right for
Crohn's DiseaseUlcerative Colitis
Takeda 192
Large-scale testing (Phase 3)Study completedNCT01369329
What this trial is testing

Evaluate the Safety and Efficacy of Ustekinumab in Patients With Moderately to Severely Active Crohn's Disease Who Have Failed or Are Intolerant to Tumor Necrosis Factor (TNF) Antagonist Therapy (UNITI-1)

Who this might be right for
Crohn's DiseaseIBDColitis+1 more
Janssen Research & Development, LLC 769
Early research (Phase 1)Looking for participantsNCT06754891
What this trial is testing

Clinical Trial of TQH3906 Capsules for the Treatment of Adult Patients With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease

Who this might be right for
Inflammatory Bowel Diseases
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. 135
Large-scale testing (Phase 3)Looking for participantsNCT06100289
What this trial is testing

Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease

Who this might be right for
Ulcerative ColitisCrohn's Disease
Takeda 70
Testing effectiveness (Phase 2)Study completedNCT02531113
What this trial is testing

Efficacy and Safety Trial of RPC1063 for Moderate to Severe Crohn's Disease

Who this might be right for
Crohn's Disease
Celgene 69
Large-scale testing (Phase 3)Study completedNCT03345836
What this trial is testing

The Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Biologic Therapy

Who this might be right for
Crohn's Disease
AbbVie 624
Large-scale testing (Phase 3)Ended earlyNCT00295165
What this trial is testing

Efficacy (Induction of Response/Remission) and Safety Study in Patients With Moderate to Severe Crohn's Disease

Who this might be right for
Crohn Disease
Genzyme, a Sanofi Company 33
Testing effectiveness (Phase 2)Active Not RecruitingNCT05910528
What this trial is testing

Afimkibart (RO7790121) for the Treatment of Moderate to Severe Active Crohn's Disease

Who this might be right for
Crohns Disease
Hoffmann-La Roche 21
Large-scale testing (Phase 3)Looking for participantsNCT07298421
What this trial is testing

Assess the Pharmacokinetics, Effectiveness and Safety of Afimkibart for Induction and Maintenance Therapy in Children With Moderately to Severely Active Crohn's Disease

Who this might be right for
Moderately to Severely Active Crohns Disease
Hoffmann-La Roche 100
Testing effectiveness (Phase 2)WithdrawnNCT02913508
What this trial is testing

Vedolizumab Subcutaneous (SC) Versus Intravenous (IV) in Ulcerative Colitis or Crohn's Disease

Who this might be right for
Ulcerative ColitisCrohn's Disease
Takeda
Large-scale testing (Phase 3)Study completedNCT04673357
What this trial is testing

Ustekinumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn Disease
Janssen Research & Development, LLC 101
Large-scale testing (Phase 3)Looking for participantsNCT05995353
What this trial is testing

Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn's Disease
AbbVie 110
Large-scale testing (Phase 3)Study completedNCT01277666
What this trial is testing

Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease

Who this might be right for
Crohn's Disease
GlaxoSmithKline 608
Large-scale testing (Phase 3)Study completedNCT00032799
What this trial is testing

Safety and Efficacy of Natalizumab in the Treatment of Crohn's Disease

Who this might be right for
Crohn's Disease
Biogen 905
Not applicableActive Not RecruitingNCT05841537
What this trial is testing

An Observational Study to Assess Change in Disease Activity and Adverse Events In Adult Participants With Moderate to Severe Active Crohn's Disease (CD)

Who this might be right for
Crohn's Disease
AbbVie 1,019
Large-scale testing (Phase 3)Looking for participantsNCT07184944
What this trial is testing

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn's Disease
Sanofi 751
Not applicableStudy completedNCT01218360
What this trial is testing

Observational Study of Disease Severity in Participants Diagnosed With Crohn's Disease and Long Term Impact of Treatment Strategies in Participants With Moderate to Severe Crohn's Disease (Protocol P06484)

Who this might be right for
Crohn Disease
Merck Sharp & Dohme LLC 71
Not applicableStudy completedNCT05192863
What this trial is testing

Vedolizumab in Adults With Crohn's Disease (CD)

Who this might be right for
Crohn's Disease
Takeda 72
Next Page